Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling ; volume:13 ; number:1 ; day:15 ; month:6 ; year:2023 ; pages:1-9 ; date:12.2023
EJNMMI Research ; 13, Heft 1 (15.6.2023), 1-9, 12.2023
- Urheber
-
Siebinga, Hinke
Hendrikx, Jeroen J. M. A.
Huitema, Alwin D. R.
Wit-van der Veen, Berlinda J. de
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-023-01008-y
- URN
-
urn:nbn:de:101:1-2023092112523097264194
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Siebinga, Hinke
- Hendrikx, Jeroen J. M. A.
- Huitema, Alwin D. R.
- Wit-van der Veen, Berlinda J. de
- SpringerLink (Online service)
Ähnliche Objekte (12)
Important pharmacokinetic parameters for individualization of 177Lu‐PSMA therapy: a global sensitivity analysis for a physiologically‐based pharmacokinetic model
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Important pharmacokinetic parameters for individualization of 177Lu‐PSMA therapy: a global sensitivity analysis for a physiologically‐based pharmacokinetic model
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Important pharmacokinetic parameters for individualization of 177Lu‐PSMA therapy: a global sensitivity analysis for a physiologically‐based pharmacokinetic model
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications